CStone Pharmaceuticals
Jun Wang has a diverse work experience in the pharmaceutical industry. They started their career as a Medical Trainer at Mission Pharmacal in 1999. They then worked at Excel PharmaStudies Inc. (China), where they held roles as a CRA, Senior CRA, Clinical Project Manager, and BD Manager. In 2005, they joined ICON plc (formerly Aptiv Solutions) as a Senior CRA and later became a Clinical Project Manager, Senior CPM, and Head of SSU in SEA. In 2011, they joined Takeda as a Senior Clinical Study Manager and subsequently became an Associate Director of Clinical Operations and Director of Operations. Currently, Jun Wang is the Vice President and Head of Clinical Operations at CStone Pharmaceuticals, a position they have held since August 2020.
Jun Wang attended Beijing University Guang Hua management school from 2017 to 2018, studying Business Administration and Management. Prior to that, from 1994 to 1999, Jun Wang earned a Bachelor's degree in Public Health & Medical from Beijing University of Chinese Medicine.
This person is not in any offices
CStone Pharmaceuticals
CStone is a biopharmaceutical company focused on developing and commercializing innovative immuno-oncology and precision medicines to address the unmet medical needs of cancer patients in China and worldwide. Established at the end of 2015, CStone has assembled a world-class management team with extensive experience in innovative drug development, clinical research, and commercialization. With a strategic emphasis on immuno-oncology combination therapies, the Company has built an oncology-focused pipeline of 16 drug candidates, including 5 late-stage candidates at pivotal trials or registration stages. With an experienced team, a rich pipeline, a robust clinical development-driven business model and substantial funding, CStone’s vision is to become a world-renowned biopharmaceutical company that is leading the way to conquering cancer.